Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v1-EN
Language French English
Date Updated 2017-08-25 2017-07-17
Drug Identification Number 02190893 02190893
Brand name GLUCOBAY GLUCOBAY
Common or Proper name Acarbose Acarbose
Company Name BAYER INC BAYER INC
Ingredients ACARBOSE ACARBOSE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 120 Tablets 120 Tablets
ATC code A10BF A10BF
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-07-13 2017-07-13
Actual start date 2017-07-13 2017-07-13
Estimated end date 2017-08-25 2017-07-28
Actual end date 2017-08-24
Shortage status Resolved Actual shortage
Company comments Product available in the market.
Health Canada comments